New targeted therapy could bring relief to people with lichen planus

Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition of the skin, hair, nails, mouth and genitals.

Aardvark Therapeutics gearing up for $200 million IPO

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we

April 1, 2024

Oxford Biomedica pivots by laying off 200 people, acquiring ABL Europe amid declining total revenues

In its bid to become a pure-play cell and gene therapy CDMO, Oxford Biomedica is laying off 200 staff members in the UK and US,

September 21, 2023

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

The FDA granted accelerated approval to afamitresgene autoleucel (afami-cel, Tecelra) for treating advanced synovial sarcoma, the first engineered cell therapy indicated for a solid tumor.

August 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.